Disclosures for "Impact of Best Practice Advisory on Reducing Contraindicated Medications and Improving Medication Management in Hospitalized Patients with Parkinson’s Disease"
-
Dr. Xu has nothing to disclose.
-
Mr. Jiang has nothing to disclose.
-
Dr. Bujala has nothing to disclose.
-
Mrs. Bond has nothing to disclose.
-
Mr. Sacknovitz has nothing to disclose.
-
Dr. Dohle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion TPharmaceuticals. Dr. Dohle has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics.
-
The institution of Dr. Amodeo has received research support from Roche. The institution of Dr. Amodeo has received research support from EIP Pharma. The institution of Dr. Amodeo has received research support from Acadia. The institution of Dr. Amodeo has received research support from MJFF. The institution of Dr. Amodeo has received research support from NINDS.